Search
for

    Sort by

    Research 331–360 of 1000+

    1. Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment Clinical and Translational Science · 2025
    2. Alopecia universalis successfully treated with tofacitinib Journal of the American Academy of Dermatology · 2017 · 2 citations
    3. Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis Drug design, development and therapy · 2016 · 37 citations
    4. Application of Baricitinib in Dermatology Journal of inflammation research · 2022 · 14 citations
    5. Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis Life · 2024 · 10 citations
    6. Tofacitinib Treatment in Patients With Active COVID-19 Infection Curēus · 2021 · 2 citations
    7. Answer International Journal of Pediatrics and Adolescent Medicine · 2015 · 1 citations
    8. mTOR signaling in hair follicle and hair diseases: recent progress Frontiers in medicine · 2023
    9. Baricitinib as a treatment for myasthenia gravis: A case report Neuromuscular Disorders · 2024
    10. Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata JCI insight · 2021 · 42 citations
    11. <i>In vivo </i>CD44‐CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance European Journal of Immunology · 2006 · 33 citations
    12. Targeting of Smoothened for therapeutic gain Trends in Pharmacological Sciences · 2014 · 105 citations
    13. Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review BMJ Open · 2019 · 17 citations
    14. Pharmacologic inhibition of JAK-STAT signaling promotes hair growth Science Advances · 2015 · 159 citations
    15. Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities 2016 · 36 citations
    16. Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin Expert Review of Dermatology · 2008 · 19 citations
    17. Baricitinib for the Treatment of Alopecia Areata Drugs · 2023 · 6 citations
    18. A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system Scientific Reports · 2025 · 2 citations
    19. Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review Indian Dermatology Online Journal · 2024 · 1 citations
    20. 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study Journal of the American Academy of Dermatology · 2023 · 1 citations
    21. Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review Dermatology and Therapy · 2026
    22. Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model Journal of Investigative Dermatology · 2026
    23. Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report Frontiers in Immunology · 2025
    24. Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature Regenerative Therapy · 2022 · 8 citations
    25. Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report SAGE open medical case reports · 2023 · 1 citations
    26. 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS) Journal of Investigative Dermatology · 2024
    27. Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata The Open Dermatology Journal · 2023
    28. Epidermal γδ T cells, CD8 T cells and macrophages are increased in number in alopecia areata and express BST2 as part of an interferon-driven antiviral gene signature bioRxiv (Cold Spring Harbor Laboratory) · 2025
    29. Cholesterol promotes hair growth through activating sympathetic nerves and enhancing the proliferation of hair follicle stem cells Molecular Medicine · 2025
    30. Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2025